1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Privigen: new trials by email Literature Review of Privigen trials Research Report on Privigen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| IVIG With Rituximab vs Rituximab as First Line Treatment of Pemphigus Rituximab, IVIg - Pemphigus | Phase 2 | Active not recruiting | The University of Hong Kong | 20 | 2020-06-20 | 2025-07-08 |
Pemphigus (1)
The University of Hong Kong (1)
Hong Kong (1)